光生物调节疗法治疗头颈癌患者口腔黏膜炎的疗效:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入14项随机对照试验共869例头颈癌患者,评估光生物调节疗法(PBMT)对放化疗所致口腔黏膜炎(OM)的影响。结果显示PBMT组OM发生率自第2周起显著低于对照组,重度黏膜炎发生率自第3周起降低,OM相关疼痛亦减轻。作者鼓励未来研究进一步探讨PBMT治疗OM的最有效参数。
要点
- PBMT组OM发生率自第2周起显著低于对照组(RR=0.49),持续至第7周(RR=0.77)。
- PBMT组重度黏膜炎发生率自第3周起降低(RR=0.51),至干预结束(RR=0.45)。
- PBMT减轻OM相关疼痛(WMD=-1.09),He-Ne或InGaAlP激光10-25 mW效果最佳。
核心结论
- PBMT在降低头颈癌患者OM发生率、严重程度及疼痛方面显示出相当大的疗效。
- 作者鼓励未来研究进一步探讨PBMT治疗OM的最有效参数。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane、LILACS和Web of Science从2000年1月至2023年10月。
- 纳入14项随机对照试验,共869例头颈癌患者。
主要发现
- PBMT组OM发生率自第2周起显著低于对照组(RR=0.49,CI=0.25-0.97,I2=71%,p=0.04),持续至第7周(RR=0.77,CI=0.61-0.99,I2=89%,p=0.04)。
- PBMT组重度黏膜炎发生率自第3周起降低(RR=0.51,CI=0.29-0.90,I2=12%,p=0.02),至干预结束(RR=0.45,CI=0.24-0.85,I2=80%,p=0.01)。
- PBMT减轻OM相关疼痛(WMD=-1.09,95%CI=-1.38至-0.880,I2=13%,p<0.00001)。
- He-Ne或InGaAlP激光功率范围10-25 mW在预防和治疗OM方面显示最有利结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Numerous studies have examined the effectiveness of photobiomodulation therapy (PBMT) in reducing chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients with head and neck cancer (HNC). Despite this, there is an urgent need to update the meta-analyses on this topic. This meta-analysis aims to explore the impact of PBMT on CRT-induced OM in these patients. We conducted a systematic search in PubMed, Embase, Cochrane, LILACS, and Web of Science from January 2000 to October 2023. This search focused on randomized controlled trials (RCTs) that assessed the effects of PBMT on CRT-induced OM. The study included a total of 14 RCTs encompassing 869 patients with HNC. The incidence of OM in the PBMT group was significantly lower from the second week onwards compared to the control group (RR = 0.49, CI = 0.25-0.97, I2 = 71%, p = 0.04), and this was present until the seventh week (RR = 0.77, CI = 0.61-0.99, I2 = 89%, p = 0.04). Furthermore, the occurrence of severe mucositis in the PBMT group decreased from the third week (RR = 0.51, CI = 0.29-0.90, I2 = 12%, p = 0.02) until the conclusion of the intervention (RR = 0.45, CI = 0.24-0.85, I2 = 80%, p = 0.01). Additionally, PBMT showed beneficial effects in alleviating OM-related pain (WMD = -1.09, 95% CI = -1.38 to -0.880, I2 = 13%, p < 0.00001). The use of He-Ne or InGaAlP lasers with a power range of 10-25 mW demonstrated the most favorable outcomes in preventing and treating OM. PBMT has shown considerable efficacy in reducing the incidence, severity, and pain associated with OM in patients with HNC. Future studies are encouraged to further investigate the most effective parameters for PBMT in the management of OM.
引用
- Shen B, Zhou Y, Wu D, et al. Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials. Head Neck. 2024. PMID: 38265122. doi:10.1002/hed.27655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。